Charles River Laboratories International (NYSE:CRL) Rating Lowered to Neutral at The Goldman Sachs Group
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a note issued to investors on Friday, Marketbeat reports. They currently have a $170.00 price objective on the medical research company’s stock, down from their previous price objective […]
More Stories
My Life with the Walter Boys Season 3 Trailer Is Out! Release Date and Ending Explained!
The wait for the most anticipated American teen drama, My Life with the Walter Boys Season 3, is coming soon....
One Hundred Years of Solitude Season 2: Release Date, Cast Members, Trailer, and More
The best-selling novel One Hundred Years of Solitude by Nobel Prize-winning Colombian author García Márquez is coming back as a...
When Your Payment Provider Can No Longer Keep Up
A payment account can work perfectly well until the business starts growing. Sales rise and customers arrive from new countries,...
The Hawk Season 2 Updates: Where Did Season 1 End
Netflix’s 2026 series, The Hawk, has been released. It has received a mixed response from the audience in different parts...
Netflix’s Upcoming Sports Documentary: Mourinho Is Releasing Soon
Football fans, be ready! Netflix is about to drop one of its most-awaited sports documentaries of 2026. Mourinho is a...
Order of the Sinking Star is Ready to Launch on PlayStation 5 and TV
The creator of Braid and The Witness, Jonathan Blow, is returning with an all-new puzzle video game, Order of the...